Zobrazeno 1 - 8
of 8
pro vyhledávání: '"G P, Nordera"'
Publikováno v:
Neuroscience and Medicine. :35-41
In a previous research we have studied the effect of the stimulation of the retina, by pulsed LED’s light of different wavelength, on the spectral density of the alpha rhythms of the electroencephalogram [1] [2]. In conformity to our results and th
Publikováno v:
Neurological Sciences. 25:s89-s92
We briefly summarise biochemical anomalies of serotonin, norepinephrine, glutamic and aspartic acids, the main neurotransmitters of inhibitory and excitatory neuronal circuitries, found in primary headaches and their relationship with pathogenesis of
Publikováno v:
Clinical laboratory. 57(11-12)
Oxidative stress may be directly or indirectly involved in the pathogenesis of Parkinson's disease (PD). 8-hydroxy-2'deoxyguanosine (8-OHdG) is the major product of DNA oxidative damage but its determination in plasma or urine may have controversial
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 28
Recent studies have suggested that abnormalities of dopamine and trace amines (tyramine, octopamine, and synephrine), products of tyrosine metabolism, may constitute the metabolic events that predispose to the occurrence of cluster headache (CH) and
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 27
Migraine with aura (MwA) sufferers, at times, need specific treatments. This is the case when the auras are frequent, prolonged and cause anxiety and distress. Abnormal release of glutamate, which may trigger auras, and abnormal platelet behaviour, w
Autor:
T. Mesiano, C. Durisotti, F. Colombo, G. P. Nordera, V. Toso, Massimo Piacentino, L. Bartolomei
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 24(3)
The 3-month clinical follow-up showed a significant reduction of UPDRS III score in the group with neurophysiological monitoring (-38%, p
Autor:
I. Casetta, P. Contri, R. Marconi, P. Vanni, G. Moro, G. Coppola, M. Onofri, G. C. Comi, G. Finali, G P Nordera, G. Bino, E. Paolino, G. D'Asta, R. Sterzi, C. Chiaro, C. Scoppetta, Giorgio Giuliani, S. Meregalli, M. Piccirilli, M. Comola, Claudio Pacchetti, A. Peppe, E. Cossutta, G. Scigliano, P. Bassi, A. Agnoli, S. Gangemi, E. Fincati, Paolo Stanzione, G. Lovicu, Francesca Rossi, R. Massetani, I. Currado, G. Tomelleri, M. De Mari, Paolo Lamberti, E. Nardelli, Francesco Carella, M. Ferrarini, S. Genitrini, P. Caffarra, M. Pederzoli, G. Campanella, P. Piola, Massimo Musicco, A. Angeleri, R. Huber, F. Iemolo, Anna Rita Bentivoglio, Tommaso Caraceni, G. Trianni, G. L. Lenzi, P. Achille, Ettore Beghi, Antonella Castellano, Alessandra Solari, A. Franciosi, P. Marini, M. Gasparini, R. Freschi, S. Bandinelli, L. Curatola, Alberto Albanese, Emilia Martignoni, A. Nicolosi, F. Salsa, R. Galli, Giuseppe Nappi, P. Scaglioni, G. De Michele, R. Semprini, A. Lorizio, L. Capus, G. Giminiani
On the long term Parkinson Disease (PD) treatment is often complicated by the occurrence of motor fluctuations. To find out whether early treatment of PD with levodopa, dopaminoagonists or 1-deprenyl is associated with any difference in motor fluctua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2683360db407bcd3f5ac2ef197c47dda
http://hdl.handle.net/11392/1732126
http://hdl.handle.net/11392/1732126
Publikováno v:
European Neurology. 27:76-80
Results obtained in 22 patients with Parkinson's disease in whom treatment with standard Madopar was replaced by Madopar HBS, a CR formulation of the same product, are presented. All the patients presented with dyskinesia and akinesia phenomena relat